Kopin Corp

This management proposal requests shareholder approval to amend and restate the company’s 2020 Equity Incentive Plan to add an additional 6,000,000-share reserve and make multiple governance and administrative changes. Management frames the amendment as necessary to satisfy Nasdaq listing requirements, preserve the ability to grant incentive stock options, cap non-employee director annual award value, and strengthen controls on share recycling and dividend treatment of unvested awards. The practical effect for shareholders is modest incremental dilution—management projects a potential overhang but argues the additional reserve (approximately 3.1% of fully diluted shares based on current figures) is required to attract and retain talent in a capital-intensive technology and defense-oriented business. The proposal contains several investor-friendly features: no evergreen increases, prohibition on reusing withheld shares for new grants, ban on repricing without shareholder approval, limits on awards to non-employee directors, and no single-trigger CIC acceleration—features that mitigate some governance and dilution concerns. Approving the amendment preserves management’s flexibility to grant performance- and time-based equity awards that management says are critical for retention and alignment, and avoids the company resorting to potentially dilutive cash alternatives. Risks to shareholders include further dilution from new awards and the potential for generous grants to executives (the company disclosed sizable CEO performance awards), but the plan includes limits and committee oversight intended to control that risk. Given Kopin’s recent strategic initiatives, defense contracts, and financing activity, management contends the ability to offer meaningful equity incentives is material to executing growth plans. The Board recommends a vote FOR, asserting the benefits—talent attraction, retention and alignment with stockholder interests—outweigh the dilution, and that governance protections incorporated in the Amended Plan reduce potential abuse. Overall, a sophisticated evaluator should weigh the incremental dilution and the disclosed size of recent executive awards against the company’s need to recruit and retain specialized talent in a competitive semiconductor/MicroLED/defense market, and consider whether the plan’s anti-recycling and anti-repricing safeguards are sufficient to protect long-term shareholders.

This advisory proposal asks shareholders to approve Kopin’s executive compensation disclosures and the overall pay program for named executive officers for fiscal 2025. Management argues that compensation is structured to attract and retain experienced leadership and to align pay with performance through a mix of base salary, significant performance-based cash and equity awards, and long-term equity incentives tied to revenue, profitability and other operational goals. The company highlights recent strategic wins, including a $15.4 million award for MicroLED development, a $15.0 million strategic investment agreement, and $61 million of orders in 2025 as context for executive pay outcomes. The advisory vote is non-binding, but the Board states it considers shareholder feedback and historically received strong support (94.3% in favor in 2025), and expects to do so again; this suggests management will treat a negative result as meaningful input. Critics could point to the size of recent CEO awards (multi-hundred-thousand to multi-million-dollar equity grants and performance targets) and the potential for pay outcomes to be realized even when broader shareholders may not have proportionate returns; they may also note dilution implications from large equity grants disclosed in the proxy. Management’s counterargument emphasizes governance safeguards (independent Compensation Committee, use of an independent compensation consultant, clawback policy, and stock ownership guidelines) and that a significant portion of pay is “at-risk,” tied to measurable performance metrics and vesting. For an analyst, the key considerations are whether disclosed performance metrics are sufficiently rigorous and independently verifiable, whether the Compensation Committee’s discretion and historical grant practices are aligned with shareholder value creation, and whether past shareholder approval levels indicate continued shareholder support. Given the advisory nature, a negative vote would not change awards directly but would likely prompt additional shareholder engagement and could lead to changes in compensation structure or greater disclosure.